The First Egyptian Report Showing the Co-Existence of blaNDM-25, blaOXA-23, blaOXA-181, and blaGES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR

Mohamed F El-Badawy,1,2 Shaymaa W El-Far,1 Shaker S Althobaiti,3 Fatma I Abou- Elazm,2 Mohamed M Shohayeb4 1Division of Pharmaceutical Microbiology, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia; 2Department of Microbiology a...

Full description

Bibliographic Details
Main Authors: El-Badawy MF, El-Far SW, Althobaiti SS, Abou- Elazm FI, Shohayeb MM
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:Infection and Drug Resistance
Subjects:
mht
Online Access:https://www.dovepress.com/the-first-egyptian-report-showing-the-co-existence-of-blandm-25-blaoxa-peer-reviewed-article-IDR
id doaj-d35407e7b31a4633b272e8c614042059
record_format Article
spelling doaj-d35407e7b31a4633b272e8c6140420592020-11-25T02:37:49ZengDove Medical PressInfection and Drug Resistance1178-69732020-04-01Volume 131237125053395The First Egyptian Report Showing the Co-Existence of blaNDM-25, blaOXA-23, blaOXA-181, and blaGES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCREl-Badawy MFEl-Far SWAlthobaiti SSAbou- Elazm FIShohayeb MMMohamed F El-Badawy,1,2 Shaymaa W El-Far,1 Shaker S Althobaiti,3 Fatma I Abou- Elazm,2 Mohamed M Shohayeb4 1Division of Pharmaceutical Microbiology, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia; 2Department of Microbiology and Immunology, Faculty of Pharmacy, Misr University for Science and Technology, 6th of October City, Egypt; 3King Fahad Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia; 4Department of Microbiology and Biotechnology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, EgyptCorrespondence: Mohamed F El-BadawyDivision of Pharmaceutical Microbiology, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Kingdom of Saudi ArabiaTel +20-103-205-9964Email m.elbadawy@tu.edu.saBackground and Objective: The emergence of carbapenem-resistant K. pneumoniae (CRKP) continues to escalate and is alarming because of the emergence of pan drug-resistant strains. The objective of this study was to investigate the existence of 12 carbapenemase genes among CRKP clinical isolates.Methods: Ninety-six Klebsiella spp. clinical isolates were collected. The isolates were identified phenotypically and genotypically. These isolates were screened for susceptibility to 24 different antibiotics. The modified Hodge test (MHT) and the Carba Nordmann/Poirel (NP) test were used to phenotypically screen carbapenem-resistant strains for carbapenemase production. Phenotypic characterization of carbapenemases was performed using the combined disk synergy test (CDST). Additionally, the presence of 12 carbapenemase genes in CRKP isolates was investigated. The DNA sequence of blaNDM and blaGES genes was determined. The BOX-PCR technique was used to determine the clonal relationship between CRKP isolates.Results: All carbapenem-resistant isolates were related to K. pneumoniae. Susceptibility testing showed that 19.79% (19/96) of the collected isolates were carbapenem-resistant. Of the CRKP isolates, 68.42% (13/19) tested positive for the MHT and Carba NP test. CDST showed that 42.11% (8/19), 63.16% (12/19), 47.37% (9/19), and 73.68% (14/19) of the CRKP isolates tested positive for the inhibitory effect of clavulanic acid, sulbactam, phenylboronic acid, and tazobactam, respectively, while 84.21% (16/19) and 68.42% (13/16) tested positive for the inhibitory effect of EDTA and mercaptopropionic acid, respectively. It was found that 10.53% (2/19) of the isolates tested positive for the inhibitory effect of sodium chloride. Molecular investigation of carbapenemases showed that 26.32% (5/19), 73.68% (14/19), 21.05% (4/19), 10.53% (2/19), and 5.26% (1/19) of the isolates tested positive for blaNDM, blaOXA-48, blaOXA-181, blaOXA-51, and blaOXA-23, respectively. None of the isolates tested positive for blaOXA-40 and blaOXA-58. Two allelic variants of blaNDM (blaNDM-1 and blaNDM-25) were detected. BOX-PCR revealed high clonal relatedness between CRKP isolates.Conclusion: MHT was more sensitive than Carba NP test for evaluating carbapenemase production and class D carbapenemase genes were the most prevalent of the 12 carbapenemase genes that were evaluated.Keywords: carbapenemases, CRKP, BOX-PCR, blaNDM-25, MHT, CDSThttps://www.dovepress.com/the-first-egyptian-report-showing-the-co-existence-of-blandm-25-blaoxa-peer-reviewed-article-IDRcarbapenemasescrkpbox-pcrblandm-25mhtcdst
collection DOAJ
language English
format Article
sources DOAJ
author El-Badawy MF
El-Far SW
Althobaiti SS
Abou- Elazm FI
Shohayeb MM
spellingShingle El-Badawy MF
El-Far SW
Althobaiti SS
Abou- Elazm FI
Shohayeb MM
The First Egyptian Report Showing the Co-Existence of blaNDM-25, blaOXA-23, blaOXA-181, and blaGES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR
Infection and Drug Resistance
carbapenemases
crkp
box-pcr
blandm-25
mht
cdst
author_facet El-Badawy MF
El-Far SW
Althobaiti SS
Abou- Elazm FI
Shohayeb MM
author_sort El-Badawy MF
title The First Egyptian Report Showing the Co-Existence of blaNDM-25, blaOXA-23, blaOXA-181, and blaGES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR
title_short The First Egyptian Report Showing the Co-Existence of blaNDM-25, blaOXA-23, blaOXA-181, and blaGES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR
title_full The First Egyptian Report Showing the Co-Existence of blaNDM-25, blaOXA-23, blaOXA-181, and blaGES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR
title_fullStr The First Egyptian Report Showing the Co-Existence of blaNDM-25, blaOXA-23, blaOXA-181, and blaGES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR
title_full_unstemmed The First Egyptian Report Showing the Co-Existence of blaNDM-25, blaOXA-23, blaOXA-181, and blaGES-1 Among Carbapenem-Resistant K. pneumoniae Clinical Isolates Genotyped by BOX-PCR
title_sort first egyptian report showing the co-existence of blandm-25, blaoxa-23, blaoxa-181, and blages-1 among carbapenem-resistant k. pneumoniae clinical isolates genotyped by box-pcr
publisher Dove Medical Press
series Infection and Drug Resistance
issn 1178-6973
publishDate 2020-04-01
description Mohamed F El-Badawy,1,2 Shaymaa W El-Far,1 Shaker S Althobaiti,3 Fatma I Abou- Elazm,2 Mohamed M Shohayeb4 1Division of Pharmaceutical Microbiology, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif, Kingdom of Saudi Arabia; 2Department of Microbiology and Immunology, Faculty of Pharmacy, Misr University for Science and Technology, 6th of October City, Egypt; 3King Fahad Armed Forces Hospital, Jeddah, Kingdom of Saudi Arabia; 4Department of Microbiology and Biotechnology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, EgyptCorrespondence: Mohamed F El-BadawyDivision of Pharmaceutical Microbiology, Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Kingdom of Saudi ArabiaTel +20-103-205-9964Email m.elbadawy@tu.edu.saBackground and Objective: The emergence of carbapenem-resistant K. pneumoniae (CRKP) continues to escalate and is alarming because of the emergence of pan drug-resistant strains. The objective of this study was to investigate the existence of 12 carbapenemase genes among CRKP clinical isolates.Methods: Ninety-six Klebsiella spp. clinical isolates were collected. The isolates were identified phenotypically and genotypically. These isolates were screened for susceptibility to 24 different antibiotics. The modified Hodge test (MHT) and the Carba Nordmann/Poirel (NP) test were used to phenotypically screen carbapenem-resistant strains for carbapenemase production. Phenotypic characterization of carbapenemases was performed using the combined disk synergy test (CDST). Additionally, the presence of 12 carbapenemase genes in CRKP isolates was investigated. The DNA sequence of blaNDM and blaGES genes was determined. The BOX-PCR technique was used to determine the clonal relationship between CRKP isolates.Results: All carbapenem-resistant isolates were related to K. pneumoniae. Susceptibility testing showed that 19.79% (19/96) of the collected isolates were carbapenem-resistant. Of the CRKP isolates, 68.42% (13/19) tested positive for the MHT and Carba NP test. CDST showed that 42.11% (8/19), 63.16% (12/19), 47.37% (9/19), and 73.68% (14/19) of the CRKP isolates tested positive for the inhibitory effect of clavulanic acid, sulbactam, phenylboronic acid, and tazobactam, respectively, while 84.21% (16/19) and 68.42% (13/16) tested positive for the inhibitory effect of EDTA and mercaptopropionic acid, respectively. It was found that 10.53% (2/19) of the isolates tested positive for the inhibitory effect of sodium chloride. Molecular investigation of carbapenemases showed that 26.32% (5/19), 73.68% (14/19), 21.05% (4/19), 10.53% (2/19), and 5.26% (1/19) of the isolates tested positive for blaNDM, blaOXA-48, blaOXA-181, blaOXA-51, and blaOXA-23, respectively. None of the isolates tested positive for blaOXA-40 and blaOXA-58. Two allelic variants of blaNDM (blaNDM-1 and blaNDM-25) were detected. BOX-PCR revealed high clonal relatedness between CRKP isolates.Conclusion: MHT was more sensitive than Carba NP test for evaluating carbapenemase production and class D carbapenemase genes were the most prevalent of the 12 carbapenemase genes that were evaluated.Keywords: carbapenemases, CRKP, BOX-PCR, blaNDM-25, MHT, CDST
topic carbapenemases
crkp
box-pcr
blandm-25
mht
cdst
url https://www.dovepress.com/the-first-egyptian-report-showing-the-co-existence-of-blandm-25-blaoxa-peer-reviewed-article-IDR
work_keys_str_mv AT elbadawymf thefirstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT elfarsw thefirstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT althobaitiss thefirstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT abouelazmfi thefirstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT shohayebmm thefirstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT elbadawymf firstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT elfarsw firstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT althobaitiss firstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT abouelazmfi firstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
AT shohayebmm firstegyptianreportshowingthecoexistenceofblandm25blaoxa23blaoxa181andblages1amongcarbapenemresistantkpneumoniaeclinicalisolatesgenotypedbyboxpcr
_version_ 1724793178757791744